US equities
|
MU
$795.41
▲+0.02%
SNDK
$1,037.40
▲+0.00%
NVDA
$200.13
▲+0.00%
AMD
$488.78
▲+0.00%
SKHY
$143.07
▲+0.00%
INTC
$58.27
▲+0.00%
TSLA
$385.19
▲+0.00%
SPCX
$135.92
▲+0.00%
MU
$795.41
▲+0.02%
SNDK
$1,037.40
▲+0.00%
NVDA
$200.13
▲+0.00%
AMD
$488.78
▲+0.00%
SKHY
$143.07
▲+0.00%
INTC
$58.27
▲+0.00%
TSLA
$385.19
▲+0.00%
SPCX
$135.92
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Lipocine Inc. - Common Stock
(NQ:
LPCN
)
1.440
UNCHANGED
Delayed Quote
Updated: 4:00 PM EST, Nov 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lipocine Inc. - Common Stock
< Previous
1
2
3
Next >
Algorhythm Holdings (NASDAQ: RIME) Introduces Azure P2P™ Targeting 24/7 Renewable Power for Data Centers as Restructuring Advances
October 08, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Energy
On Friday, there are stocks with unusual volume. Let's take a look.
↗
April 10, 2026
Which stocks have an unusual volume on Friday?
Via
Chartmill
Topics
Artificial Intelligence
In today's session, these stocks are experiencing unusual volume.
↗
April 09, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
April 08, 2026
Via
Chartmill
LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024
↗
May 09, 2024
LPCN stock results show that Lipocine beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023
↗
March 07, 2024
LPCN stock results show that Lipocine beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Is Lipocine (LPCN) Stock Up 32% Today?
↗
July 27, 2023
Lipocine (LPCN) stock is rising higher on Thursday after the company released positive results from a Phase 2 clinical trial.
Via
InvestorPlace
On Tuesday, there are stocks with unusual volume. Let's take a look.
↗
April 07, 2026
Via
Chartmill
On Monday, there are stocks with unusual volume. Let's take a look.
↗
April 06, 2026
Via
Chartmill
Here are the top movers in Thursday's session.
↗
April 02, 2026
Via
Chartmill
Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session.
↗
April 02, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
April 02, 2026
Via
Chartmill
2026 Asset Growth: Why Federal Compliance Is the New Metric
January 19, 2026
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC.
From
Equity Insider
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 06, 2025
Via
Benzinga
LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024
↗
August 08, 2024
LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 19, 2024
Via
Benzinga
7 Penny Biotech Stocks to Triple Your Investment
↗
May 28, 2024
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
March 13, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
February 01, 2024
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 18, 2024
Via
Benzinga
Why Lipocine Stock Is Moving Higher Today?
↗
July 27, 2023
Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
Why Is National Vision (EYE) Stock Down 12% Today?
↗
July 27, 2023
National Vision (EYE) stock is dropping on Thursday as a deal it has with Walmart (WMT) is going to come to an end in 2024.
Via
InvestorPlace
Why Is Yellow (YELL) Stock Down 27% Today?
↗
July 27, 2023
Yellow (YELL) stock is falling on Thursday as reports claim the transportation company is preparing to file for bankruptcy.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 27, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 27, 2023
It's time to start off the day right with an overview of all the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
May 11, 2023
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.
Via
Benzinga
< Previous
1
2
3
Next >
